About Gudrun Stengel
Form D filings for Alida Biosciences from 2021 to 2024 list Gudrun Stengel as president and CEO, director.
Gudrun Stengel first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Gudrun Stengel in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Gudrun Stengel works with at each company, as listed on that company's latest Form D.
Alida Biosciences Inc. · Form D, Jun 17, 2024